168 related articles for article (PubMed ID: 33132443)
41. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
42. Multiple cranial nerve enhancement on MRI in primary Sjögren's syndrome.
Sakai K; Hamaguchi T; Yamada M
Intern Med; 2010; 49(9):857-9. PubMed ID: 20453408
[TBL] [Abstract][Full Text] [Related]
43. [Diagnostics of Sjögren's syndrome by means of anti-alpha-fodrin antibody].
Tilch DA; Schäfer HG; Winter R
Klin Monbl Augenheilkd; 2007 May; 224(5):427-30. PubMed ID: 17516374
[TBL] [Abstract][Full Text] [Related]
44. [Sjögren's syndrome associated with childhood-onset systemic lupus erythematosus].
Iwata N; Mori M; Miyamae T; Ito S; Imagawa T; Yokota S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Jun; 31(3):166-71. PubMed ID: 18587227
[TBL] [Abstract][Full Text] [Related]
45. Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
Pericot I; Brieva L; Tintoré M; Río J; Sastre-Garriga J; Nos C; Montalban X
Mult Scler; 2003 Jun; 9(3):256-9. PubMed ID: 12814172
[TBL] [Abstract][Full Text] [Related]
46. [Sjögren's syndrome - case report].
Ladino RM; Gasitulli OA; Campos MX
Rev Chil Pediatr; 2015; 86(1):47-51. PubMed ID: 26223398
[TBL] [Abstract][Full Text] [Related]
47. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
Toker E; Yavuz S; Direskeneli H
Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
[TBL] [Abstract][Full Text] [Related]
48. Optic Neuropathy Associated with Primary Sjögren's Syndrome: A Case Series.
Bak E; Yang HK; Hwang JM
Optom Vis Sci; 2017 Apr; 94(4):519-526. PubMed ID: 28272192
[TBL] [Abstract][Full Text] [Related]
49. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
[TBL] [Abstract][Full Text] [Related]
50. Recurrent parotid gland enlargement as an initial manifestation of Sjögren syndrome in children.
Mizuno Y; Hara T; Hatae K; Hirano T; Ueda K; Nakamura N; Mizoguchi Y
Eur J Pediatr; 1989 Feb; 148(5):414-6. PubMed ID: 2920746
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
Sirois DA; Natelson B
J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
[TBL] [Abstract][Full Text] [Related]
52. Diffuse Cystic Lung Disease as the Presenting Manifestation of Sjögren Syndrome.
Gupta N; Wikenheiser-Brokamp KA; Fischer A; McCormack FX
Ann Am Thorac Soc; 2016 Mar; 13(3):371-5. PubMed ID: 26741500
[TBL] [Abstract][Full Text] [Related]
53. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
[TBL] [Abstract][Full Text] [Related]
54. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
55. [The diagnostic value of anti-SSA antibody in primary Sjögren's syndrome].
Li MT; Zhao Y; Zheng WJ; Su JM; Wu QJ; Jiang Y; Xu D; Zhang W; Zhang FC; Dong Y
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):410-3. PubMed ID: 20646416
[TBL] [Abstract][Full Text] [Related]
56. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome.
Hammenfors DS; Brun JG; Jonsson R; Jonsson MV
Clin Exp Rheumatol; 2015; 33(1):56-62. PubMed ID: 25535773
[TBL] [Abstract][Full Text] [Related]
58. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome.
Tengnér P; Halse AK; Haga HJ; Jonsson R; Wahren-Herlenius M
Arthritis Rheum; 1998 Dec; 41(12):2238-48. PubMed ID: 9870881
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren's syndrome.
Chung JK; Kim MK; Wee WR
Br J Ophthalmol; 2012 Feb; 96(2):240-5. PubMed ID: 21558290
[TBL] [Abstract][Full Text] [Related]
60. Primary Sjögren syndrome in a 2-year-old patient: role of the dentist in diagnosis and dental management with a 6-year follow-up.
De Oliveira MA; De Rezende NP; Maia CM; Gallottini M
Int J Paediatr Dent; 2011 Nov; 21(6):471-5. PubMed ID: 21623979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
